Cisplatin-induced cytoxicity: Is the nucleus relevant?

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 1, 2008, Pages

  Sheikh Hamad, David ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BREFELDIN A; CISPLATIN; CYCLIN DEPENDENT KINASE 2; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; RIBONUCLEOTIDE REDUCTASE; THIOL GROUP; THYMIDYLATE SYNTHASE; TUNICAMYCIN;

APOPTOSIS; CELL PROLIFERATION; CYTOTOXICITY; DNA CROSS LINKING; EDITORIAL; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ANIMAL; CELL NUCLEUS; CYTOPLASM; DRUG EFFECT; KIDNEY; KIDNEY TUBULE; MOUSE; NOTE; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; CELL NUCLEUS; CISPLATIN; CYCLIN-DEPENDENT KINASE 2; CYTOPLASM; KIDNEY; KIDNEY TUBULES; MICE;

EID: 49949088446     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90293.2008     Document Type: Editorial

References (20)

1. Anderson ME, Naganuma A, Meister A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB J 4: 3251-3255, 1990.
2. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 10: 1663-1682, 2003.
3. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity. II. Morphologic observations. J Pharmacol Exp Ther 213: 551-556, 1980.
4. Goren MP, Wright RK, Horowitz ME. Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemother Pharmacol 18: 69-73, 1986.
5. Hiromura K, Pippin JW, Blonski MJ, Roberts JM, Shankland SJ. The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogene 21: 1750-1758, 2002.
6. Jones DP, Chesney RW. Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin. Curr Opin Pediatr 7: 208-213, 1995.
7. Keenan SM, Bellone C, Baldassare JJ. Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase. J Biol Chem 276: 22404-22409, 2001.
8. Levi J, Jacobs C, Kalman SM, McTigue M, Weiner MW. Mechanism of cis-platinum nephrotoxicity. I. Effects of sulfhydryl groups in rat kidneys. J Pharmacol Exp Ther 213: 545-550, 1980.
9. Litterst CL, Torres IJ, Arnold S, McGunagle D, Furner R, Sikic BI, Guarino AM. Adsorption of antineoplastic drugs following large-volume ip administration to rats. Cancer Treat Rep 66: 147-155, 1982.
10. Long DF, Repta AJ. Cisplatin: chemistry, distribution and biotransformation. Biopharm Drug Dispos 2: 1-16, 1981.
11. Megyesi J, Safirstein RL, Price PM. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101: 777-782, 1998.
12. Price PM, Safirstein RL, Megyesi J. Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286: F378-F384, 2004.
13. Price PM, Yu F, Kaldis P, Aleem E, Nowak G, Safirstein RL, Megyesi J. Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 17: 2434-2442, 2006.
14. Ries F, Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8: 368-379, 1986.
15. Sheikh-Hamad D, Cacini W, Buckley AR, Isaac J, Truong LD, Tsao CC, Kishore BK. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78: 147-155, 2004.
16. Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 8: 1640-1644, 1997.
17. Yu F, Megyesi J, Safirstein RL, Price PM. Identification of the functional domain of p21(WAF1/CIP1) that protects cells from cisplatin cytotoxicity. Am J Physiol Renal Physiol 289: F514-F520, 2005.
18. Yu F, Megyesi J, Safirstein RL, Price PM. Involvement of the CDK2-E2F1 pathway in cisplatin cytotoxicity in vitro and in vivo. Am J Physiol Renal Physiol 293: F52-F59, 2007.
19. Yu F, Megyesi JK, Price PM. Cytoplasmic initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol (First published April 9, 2008). doi:10.1152/ajprenal.00593.2007.
20. Zwelling LA, Kohn KW, Ross WE, Ewig RA, Anderson T. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II). Cancer Res 38: 1762-1768, 1978.